Cue Biopharma Newsroom

Stifel Nicolaus Sticks to Their Buy Rating for Cue Biopharma (CUE)

TipRanksJul 29 06:17 ET

JMP Securities Maintains Market Outperform on Cue Biopharma, Lowers Price Target to $2

BenzingaJul 26 14:13 ET

Cue Biopharma Analyst Ratings

BenzingaJul 26 09:54 ET

Piper Sandler Maintains Cue Biopharma(CUE.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsJul 26 07:31 ET

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Tenaya Therapeutics (TNYA) and Cue Biopharma (CUE)

TipRanksJul 26 07:07 ET

JMP Securities Maintains Cue Biopharma(CUE.US) With Buy Rating, Cuts Target Price to $2

Moomoo NewsJul 26 01:32 ET

Cue Biopharma Receives 'Buy' Rating Amid Strategic Shift and Promising Autoimmune Therapeutics Pipeline

TipRanksJul 26 00:37 ET

Cue Biopharma's Promising Future: A Comprehensive Buy Rating Justification

TipRanksMay 16 00:30 ET

Oppenheimer Reaffirms Their Buy Rating on Cue Biopharma (CUE)

TipRanksMay 10 08:00 ET

Cue Biopharma Analyst Ratings

BenzingaApr 9 08:22 ET

Oppenheimer Maintains Outperform on Cue Biopharma, Maintains $10 Price Target

BenzingaApr 9 08:22 ET

Oppenheimer Remains a Buy on Cue Biopharma (CUE)

TipRanksApr 9 07:50 ET

Cue Biopharma (CUE) Gets a Buy From Stifel Nicolaus

TipRanksApr 9 07:10 ET

Cue Biopharma Analyst Ratings

BenzingaApr 3 12:06 ET

Piper Sandler Remains a Buy on Cue Biopharma (CUE)

TipRanksApr 3 07:11 ET

Cue Biopharma Analyst Ratings

BenzingaMar 13 09:04 ET

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE)

TipRanksFeb 26 08:10 ET

Cue Biopharma (CUE) Gets a Buy From Piper Sandler

TipRanksFeb 20 07:45 ET

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Cue Biopharma (CUE)

TipRanksNov 13, 2023 14:10 ET

Analysts Conflicted on These Healthcare Names: Cue Biopharma (CUE) and Mirati Therapeutics (MRTX)

TipRanksNov 7, 2023 00:41 ET